Evidence map›Paper›PMID 28332089›Full record

ReviewGeneral thoracic and cardiovascular surgery2017

Surgery for total anomalous pulmonary venous connection: primary sutureless repair vs. conventional repair.

Naoki Yoshimura, Kazuaki Fukahara, Akio Yamashita, Toshio Doi, Katsunori Takeuchi, Shigeyuki Yamashita, Takahiro Homma, Shigeki Yokoyama, Masaya Aoki, Yuki Ikeno

Abstract readReview
PubMed Publisher
In one paragraph

Review in General thoracic and cardiovascular surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Naoki YoshimuraDepartment of Cardiothoracic Surgery, University of Toyama, Graduate School of Medicine, 2630 Sugitani, Toyama, 930-0194, Toyama, Japan. ynaoki@med.u-toyama.ac.jp.ORCID http://orcid.org/0000-0002-4265-0947
Kazuaki FukaharaDepartment of Cardiothoracic Surgery, University of Toyama, Graduate School of Medicine, 2630 Sugitani, Toyama, 930-0194, Toyama, Japan.
Akio YamashitaDepartment of Cardiothoracic Surgery, University of Toyama, Graduate School of Medicine, 2630 Sugitani, Toyama, 930-0194, Toyama, Japan.
Toshio DoiDepartment of Cardiothoracic Surgery, University of Toyama, Graduate School of Medicine, 2630 Sugitani, Toyama, 930-0194, Toyama, Japan.
Katsunori TakeuchiDepartment of Cardiothoracic Surgery, University of Toyama, Graduate School of Medicine, 2630 Sugitani, Toyama, 930-0194, Toyama, Japan.
Shigeyuki YamashitaDepartment of Cardiothoracic Surgery, University of Toyama, Graduate School of Medicine, 2630 Sugitani, Toyama, 930-0194, Toyama, Japan.
Takahiro HommaDepartment of Cardiothoracic Surgery, University of Toyama, Graduate School of Medicine, 2630 Sugitani, Toyama, 930-0194, Toyama, Japan.
Shigeki YokoyamaDepartment of Cardiothoracic Surgery, University of Toyama, Graduate School of Medicine, 2630 Sugitani, Toyama, 930-0194, Toyama, Japan.
Masaya AokiDepartment of Cardiothoracic Surgery, University of Toyama, Graduate School of Medicine, 2630 Sugitani, Toyama, 930-0194, Toyama, Japan.
Yuki IkenoDepartment of Cardiothoracic Surgery, University of Toyama, Graduate School of Medicine, 2630 Sugitani, Toyama, 930-0194, Toyama, Japan.
University of Toyama · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite recent advances in surgical technique and perioperative care, the surgical correction of total anomalous pulmonary venous connection (TAPVC) remains a challenge. The major complication and the main cause of reoperation in TAPVC surgery are the occurrence of pulmonary venous obstruction (PVO). In the 1990s, sutureless repair was introduced as a technique to relieve PVO after TAPVC repair. Following the favorable outcomes for postoperative PVO, the indications for sutureless repair as a primary operation have been expanded to include infants who have preoperative PVO or those at risk of developing PVO after the repair of TAPVC. However, the indications of "prophylactic" primary sutureless repair still remain controversial. Recent studies have shown that normal-risk patients have excellent early and long-term outcomes and a low incidence of reoperation for postoperative PVO. Most patients who survived beyond 2 years after TAPVC surgery were in NYHA class I and offered good outcomes. Although favorable early and mid-term outcomes of primary sutureless repair are reported, the long-term outcomes of this technique are still unclear. The influence of non-contractile pericardial tissue interposed between the PV vessel wall and LA myocardium on the atrial function is also unclear in patients who undergo sutureless repair. Another disadvantage of primary sutureless repair is potential bleeding from the gap between the confluence and pericardium into the posterior mediastinum or pleural cavity. Thus, it might be best for primary sutureless repair to be indicated for high-risk infants, such as those with TAPVC associated with single-ventricular physiology, mixed-type TAPVC, or small PV confluence.

Indexed as

HumansInfantInfant, NewbornPulmonary CirculationPulmonary VeinsReoperationSutureless Surgical ProceduresVascular MalformationsVascular Surgical ProceduresPulmonary venous obstructionSutureless repairTotal anomalous pulmonary venous connection

Identifiers

PMID28332089
OpenAlexW2601222223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.